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Thomas R. Frieden, M.D., M.P.H. 
Director Acting Assistant Secretary for  
Centers for Disease Control and  
 Prevention 
1600 Clifton Road, NE 
Atlanta, GA 30333 
Jordan Barab, M.A. 
 Occupational Safety and 
 Health, Department of Labor 
Occupational Safety and Health 
 Administration 
200 Constitution Avenue, NW  
Room S2315 
Washington, DC 20210 
 
Dear Dr. Frieden and Mr. Barab: 
 
On behalf of the Institute of Medicine (IOM) Committee on Respira-
tory Protection for Healthcare Workers in the Workplace Against Novel 
H1N1 Influenza A, we are pleased to report our conclusions and recom-
mendations. At the request of the Centers for Disease Control and Pre-
vention (CDC) and the Occupational Safety and Health Administration 
(OSHA) the Institute of Medicine convened this committee to provide 
recommendations regarding the necessary respiratory protection for 
healthcare workers in their workplace against novel H1N1 influenza A 
(nH1N1). The committee was also charged with considering, to the ex-
tent feasible, the available evidence regarding the potential for exposure 
among healthcare workers; the groups of workers at highest risk; the de-
grees of risk for various patient care activities; and the extent of knowl-
edge of the virus’ transmissibility, severity, virulence, and potential to 
change. The committee was also asked to pay attention to current guid-
ance documents on personal protective equipment (PPE), particularly 
those offered by the CDC and the World Health Organization (WHO) for 
both nH1N1 as well as seasonal influenza. The committee was not 
charged with considering the economic and logistical considerations re-
garding PPE. The committee had significant concerns about the level of 
healthcare workers’ compliance with the use of PPE, recognizing the 
noteworthy controversy that exists regarding how compliance affects the 
clinical effectiveness of PPE, and therefore its relevance to clinical 
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guideline decision making. More research is needed to better understand 
and address this issue. 
To accomplish its charge within the 8-week timeframe, the commit-
tee held a 4-day meeting that included a day-and-a-half public workshop 
(Appendix A). Panel discussions focused on the current clinical experi-
ence with nH1N1, influenza transmission, clinical and community stud-
ies on preventing seasonal influenza or other respiratory virus 
transmission, risks to healthcare workers in various settings, the efficacy 
and effectiveness1 of respirators and of medical masks,2 and decision 
making in infection control. Additionally, 12 individuals provided com-
ments during the public comment session. This report also benefits from 
the work of prior IOM committees and workshops that have examined 
issues related to PPE and to pandemic influenza (IOM, 2005a,b, 2006, 
2007, 2008a,b). 
This report focuses on the scientific and empirical evidence regard-
ing the efficacy of various types of personal respiratory protection tech-
nologies as one measure to protect healthcare workers against nH1N1. 
The committee concludes that an emphasis is needed on implementing a 
range of strategies across all levels of the hierarchy of controls to mini-
mize risk and decrease the number of healthcare workers and other pa-
tients exposed to patients with suspected or confirmed nH1N1. The 
committee provides the following findings and recommendations and 
provides additional detail in the report that follows.  
Studies on influenza transmission show that airborne (inhalation) 
transmission is one of the potential routes of transmission. The commit-
tee based its decisions on comparisons of the experimental evidence on 
the efficacy of respirators and medical masks and not on their effective-
ness in the clinical setting due to the fact that the availability of data is 
quite limited on clinical effectiveness. Further, clinical effectiveness re-
quires consideration of numerous implementation factors such as com-
pliance and availability of supply. N95 respirators are documented to 
filter out 95 to 99 percent of relevant particles and have maximum effec-
tiveness when properly fitted to the face of users through fit testing (Qian 
 
1Efficacy is defined as the extent to which a specific intervention produces a beneficial 
result under ideal circumstances. Effectiveness is defined as a measure of the accuracy or 
success of an intervention when carried out in an average clinical environment (PDR, 
1995).  
2The committee uses the term medical masks to refer to procedure masks and surgical 
masks. Because of the wide variety in the types of masks referred to in the articles and 
presentations reviewed by the committee, the committee uses this term to encompass all 
types of masks used in healthcare facilities.  
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et al., 1998). Research results on the filtration and fit of medical masks 
show wide variation in penetration of aerosol particles (4 percent to 90 
percent) and inadequate fit suggesting that the use of medical masks is 
unlikely to be effective against airborne transmission (Oberg and 
Brosseau, 2008). Medical masks are not designed to provide a tight seal 
to the face, and there was considerable evidence in laboratory studies of 
leakage of materials under and around the medical mask from the un-
fitted margins. The committee found a paucity of studies comparing the 
clinical effectiveness of respirators versus medical masks in preventing 
the transmission of influenza viruses. Several studies are underway or in 
publication.  
  
Recommendation 1: Use Fit-Tested N95 Respirators 
Healthcare workers (including those in non-hospital settings) 
who are in close contact with individuals with nH1N1 influ-
enza or influenza-like illnesses should use fit-tested N95 respi-
rators or respirators that are demonstrably more effective as 
one measure in the continuum of safety and infection control 
efforts to reduce the risk of infection.  
• The committee endorses the current CDC guidelines 
and recommends that these guidelines should be con-
tinued until or unless further evidence can be provided 
to the effect that other forms of protection or other 
guidelines are equally or more effective.  
• Employers should ensure that the use and fit testing of 
N95 respirators be conducted in accordance with 
OSHA regulations, and healthcare workers should use 
the equipment as required by regulations and em-
ployer policies. 
 
Healthcare organizations and workers need consistent and clear 
nH1N1 guidelines that can be implemented across all healthcare facili-
ties. The committee again acknowledges that many implementation is-
sues factor into the policy decision-making process for PPE guidance, 
but the committee was not charged with considering these factors, which 
include cost, availability of equipment, and other considerations in the 
implementation of such guidance. For example, policies may be influ-
enced by the degree to which healthcare workers are effectively immu-
nized with nH1N1 influenza vaccines.  
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It is not the intention of the committee to recommend that all health-
care workers use N95 respirators, rather the use of respirators should be 
for those in initial contact with individuals presenting with unidentified 
febrile respiratory illnesses and those healthcare workers in close contact 
with individuals with confirmed or suspected nH1N1. The committee 
acknowledges that this recommendation, if implemented, could have 
broader implications for clinical practice, including seasonal influenza 
and other potential airborne infections; however, the committee was 
charged only with addressing respiratory protection issues related to 
nH1N1. As noted throughout the report, the committee emphasizes that 
respiratory protection is a critical component in the hierarchy of infection 
prevention and control strategies.  
The need for research in a number of areas was striking. Due to the 
lack of a strong and conclusive evidence base, the committee concluded 
that determination of the relative contribution of each route of influenza 
transmission is essential for long-term preparedness planning. Further, 
the committee concluded that a stronger evidence base is needed regard-
ing the effectiveness of personal respiratory protection technologies in 
clinical settings as is the development of improved respiratory protection 
technologies for healthcare workers.  
 
Recommendation 2: Increase Research on Influenza Trans-
mission and Personal Respiratory Protection 
CDC centers (e.g., National Institute for Occupational Safety 
and Health; National Center for Immunization and Respira-
tory Diseases; National Center for Preparedness, Detection, 
and Control of Infectious Diseases), the National Institutes of 
Health, and other relevant federal agencies and private insti-
tutions should fund and undertake additional research to 
• resolve the unanswered questions regarding the rela-
tive contribution of various routes of influenza trans-
mission,  
• fully explore the effectiveness of personal respiratory 
protection technologies in a variety of clinical settings 
through randomized clinical trials, and 
• design and develop the next generation of personal 
respiratory protection technologies for healthcare 
workers to enhance safety, comfort, and ability to per-
form work-related tasks.  
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The committee appreciates the opportunity to provide input into the 
considerable efforts to prepare for nH1N1 that are ongoing at CDC and 
OSHA. We would be pleased to brief you and your staffs regarding the 
findings and recommendations provided in this letter report.  
 
 
 Kenneth I. Shine, M.D., Chair 
 M. E. Bonnie Rogers, Dr. P.H., Vice Chair 
 Committee on Respiratory Protection for Healthcare Workers 
 in the Workplace Against Novel H1N1 Influenza A 
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BACKGROUND 
 
The risk of influenza to healthcare workers is not a new concern, but 
the ongoing experience with novel influenza A (nH1N1) makes this issue 
even more urgent. Among the many considerations for the health and 
well-being of healthcare workers is the question about what types of per-
sonal protective equipment (PPE) (e.g., respirators, gloves, gowns, eye 
protection, and other equipment) are needed to fully protect these front-
line workers.  
This report focuses on the scientific and empirical evidence regard-
ing the efficacy of various types of personal respiratory protective 
equipment as one measure to protect healthcare workers against nH1N1. 
The committee was not charged to consider the many factors that may 
affect policy decisions for PPE guidance including economics, equip-
ment supplies, vaccine availability, immunization status,3 extent of PPE 
compliance, and logistical considerations in the implementation of such 
guidance (see Box 1). In this regard, the committee recognizes that while 
the appropriate choice of PPE may include consideration of worker com-
pliance and that PPE comfort and design contribute to clinical effective-
ness, the committee focused its examination solely on currently available 
data on the efficacy of protective respiratory equipment. Further, as dis-
cussed below, the committee views PPE as one part of a set of infection 
control strategies to reduce the potential for nH1N1 infection in health-
care workers.  
In 2008, the Institute of Medicine (IOM) released the report Prepar-
ing for an Influenza Pandemic: Personal Protective Equipment for 
Healthcare Workers; it examined the research needs in PPE and recog-
nized the many issues that need to be addressed to improve PPE use in an 
influenza pandemic (IOM, 2008b). That committee identified three areas 
in crucial need of research and policy action: (1) routes of influenza 
transmission, (2) emphasis on worker safety and the appropriate use of 
PPE, and (3) development and utilization of innovative PPE technologies 





3The committee acknowledges that vaccines will provide protection but noted the po-
tential variability in immunization response as seen in a small study in the 1957 pandemic 
in which 35 percent of vaccinated healthcare workers developed influenza compared to 
55 to 65 percent of unvaccinated healthcare workers (Blumenfeld et al., 1959).  
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 BOX 1 
 Statement of Task 
 
In response to a request from the Centers for Disease Control (CDC) 
and Prevention and the Occupational Safety and Health Administration, an 
ad hoc committee of the Institute of Medicine (IOM) will conduct a study and 
issue a letter report to the CDC director and Assistant Secretary for Occupa-
tional Safety and Health by September 1, 2009. The committee will provide 
recommendations regarding the necessary respiratory protection, as part of 
personal protective equipment (PPE), for healthcare workers in their work-
place against the novel influenza A (nH1N1) virus. Issues to be addressed to 
the extent feasible given available evidence and within the timeline for this 
letter report include: the potential for exposure to the nH1N1 virus among 
healthcare workers, which groups of workers are at risk, which patient care 
activities pose a risk of exposure and what degree of risk, and what is known 
and what is unknown about transmissibility, severity and virulence of the cur-
rent virus and how transmissibility might change. The committee will base its 
recommendations on the available current state of scientific and empirical 
evidence about nH1N1 virus, as well as its expert judgment. Economic and 
logistical considerations regarding PPE equipment will not be addressed in 
this letter report. In determining the appropriate respiratory protection for the 
U.S. healthcare workforce, attention will be given to the current PPE guid-
ance documents offered by the CDC and by the World Health Organization 
for novel H1N1 influenza and for seasonal influenza. 
 
 
reports (IOM, 2005a,b, 2006, 2007, 2008a), served as a basis for this let-
ter report, and the committee built on these efforts with information pro-
vided at the workshop as well as from recent published literature and the 
committee’s expert judgment.  
 
 
Healthcare Workers: Defining the Scope of the Term 
 
More than 13.6 million workers in the United States were employed 
in the healthcare field in 2006 with approximately 35 percent employed 
in hospitals, 23 percent in nursing and residential care facilities; and 17 
percent in offices of physicians (BLS, 2009). The 2008 IOM report de-
fined healthcare workers to encompass all workers employed by private 
and public healthcare offices and facilities as well as those working in 
home healthcare and emergency medical services (IOM, 2008b). The 
definition also included health professional students who are working at 
or receiving instruction in healthcare facilities. For this letter report, the 
committee expanded on that definition to include individuals in profes-
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sional and support services (e.g., clinical laboratories); individuals in-
volved in administration, patient care, and facilities management; and 
individuals working for private- and public-sector employers, those who 
are self-employed, and volunteers trained to provide systematic, regu-




PPE in Perspective 
 
In the continuum of safety and infection prevention efforts in health-
care facilities, PPE is one of many important components. Occupational 
safety and health measures have traditionally followed a hierarchy of 
controls—engineering controls, administrative and work practice con-
trols, and PPE. Engineering and environmental controls (e.g., ventilation, 
negative-pressure rooms, isolation rooms) are considered the first line of 
defense as they are measures that protect or affect multiple workers and 
patients and do not rely on individual compliance. Administrative and 
work practice controls include the policies, standards, procedures, and 
practices established within an organization to limit hazardous exposures 
and improve worker safety (e.g., cohorting or isolating patients, hand 
hygiene, cough etiquette, worker immunization policies, training and 
education, and organizational commitment to creating and sustaining a 
culture of worker safety). Personal protective equipment includes respi-
rators, gowns, gloves, eye protection, and hearing protection. All relevant 
work situations with the potential for infection risk (such as cleaning pa-
tient rooms and delivery of food) must be considered in addition to direct 
care of the patients. 
The infection prevention and control precautions outlined by CDC’s 
Healthcare Infection Control Practices Advisory Committee provide a 
tiered approach based on routes of transmission (Siegel et al., 2007). The 
guidelines for airborne precautions call for a range of measures in addi-
tion to standard precautions (gloves, gown, hand hygiene, etc.) including 
patient placement, personnel restrictions, exposure management, and 
individual respiratory protection measures of a fit-tested N95 or higher-
level respirator.  
During its workshop, the committee heard about many potential en-
vironmental and administrative controls that could be effective in reduc-
ing the number of healthcare workers exposed to nH1N1. These would 
include such activities as innovative triage mechanisms for individuals 
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with influenza-like illnesses, separate waiting areas for such patients, and 
single patient rooms.  
At the individual level, responsibilities incumbent on the healthcare 
worker include the use of proper hand hygiene practices, appropriate use 
of PPE, and obtaining relevant immunizations offered by the employer, 
as well as adherence to work safety practices. Hand and respiratory hy-
giene are examples of proven interventions that decrease the spread of 
infections. Unfortunately, evidence for compliance of healthcare workers 
with these measures indicates that these effective measures are signifi-
cantly underused, as are most types of PPE (IOM, 2008b). Many factors 
have been identified as reasons for this underuse including lack of time, 
lack of ready access to equipment, concerns about interference with pa-
tient care, and problems with comfort. 
The committee emphasizes that PPE needs to be viewed as one part 
of a continuum of controls to ensure worker and patient safety that range 
from engineering controls and administrative approaches to pharmaceu-
tical measures (e.g., vaccines and antivirals) and personal protective 
equipment. Further, PPE components (e.g., eye protection, respirators) 
need to be seamlessly integrated into protective ensembles that effec-




Current Guidelines Regarding nH1N1  
and Use of PPE by Healthcare Workers 
 
The committee carefully reviewed the current CDC and WHO infec-
tion control guidelines (as well as other relevant guidelines) for health-
care workers caring for patients with known or suspected nH1N1 (see 
Table 1) (CDC, 2009f; WHO, 2009a). These guidelines both recommend 
the use of hand hygiene, gloves, gowns, and eye protection, but most 
notably differ in the respiratory protection recommendations. CDC rec-
ommends a fit-tested disposable N95 respirator or better for “all health-
care personnel who enter the rooms of patients in isolation with 
confirmed, suspected, or probable novel H1N1 influenza” (CDC, 2009f).   
For emergency medical responders, the CDC recommends a fit-tested 
disposable N95 respirator for those workers “who are in close contact” 
with patients with confirmed or suspected nH1N1, for personnel 
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TABLE 1 Summary of PPE Guidelines for Care of Patients with Novel 
H1N1 Influenza A 
NOTE: Hand hygiene should be practiced consistently in all situations. 
 Type of PPE—Guidelines  










Centers for Disease Control and Prevention 
Isolation precautions1: Stan-
dard and contact precau-
tions plus eye protection 
should be used for all pa-
tient care activities for 
patients  being evaluated 
or in isolation for novel 
H1N1 
Respiratory protection: All 
healthcare personnel who 
enter the rooms of pa-
tients in isolation with 
confirmed, suspected, or 
probable novel H1N1  in-
fluenza should wear a fit-
tested disposable N95 
respirator or better  
 X X X X 
(N95) 
World Health Organization 
Per droplet precautions, 
when in direct contact 
with patients 
X     
 
Per standard precautions, 
for procedures with a risk 
for splashes onto the face 
and body 
X3 X X X3  
When performing aerosol-
generating procedures 
 X X X X2 
When completing a nasal 
swab and nasal wash 
X3 X X X3  
When collecting blood X X    
1CDC guidelines recommend that patients with confirmed, probable or suspected cases of 
nH1N1 who present for care at healthcare facilities be placed into individual rooms with 
closed doors. 
2Types include EU FFP2 and U.S. NIOSH-certified N95 respirators. 
3Guidelines call for using face protection (either a medical mask and eye-visor or gog-
gles, or a face shield). 
SOURCE: CDC, 2009f; WHO, 2009a.  
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“engaged in aerosol generating activities,” and for personnel involved in 
the “interfacility transfer” of patients with suspected or confirmed 
nH1N1 (CDC, 2009e). WHO recommends standard and droplet precau-
tions (including a medical mask, gown, gloves, eye protection, hand hy-
giene) for those working in direct contact with patients and additional 
precautions for aerosol-generating procedures including wearing a facial 
particulate respirator (WHO, 2009a). The WHO recommendations take 
into account the need for sustainability in a variety of countries and allow 
each country to put forward its own guidelines on the recommended 
level of protection based on a variety of factors. 
The recently released Canadian guidelines also provide a tiered ap-
proach based on the current behavior of the virus, recommending N95 
use for aerosol-generating procedures with direct patient contact only 
(PHAC, 2009a,b,c,d). The guidelines note an anticipation that only a mi-
nority of the patients will need to be cared for at this level, recommend-
ing the use of medical masks for direct patient interactions that do not 
include the potential for procedure-induced aerosol generation. Routine 
practices are recommended for indirect contact with nH1N1 influenza 
patients. The guidelines note that hand hygiene and respiratory hygiene 






Overview of Influenza A 
 
Influenza is a serious respiratory illness caused by infection with in-
fluenza type A or type B virus. Influenza infections peak during the win-
ter months in each hemisphere. In addition to seasonal occurrences of 
influenza, outbreaks of influenza may result in a global pandemic. The 
risk of serious illness and death from seasonal influenza is highest at the 
extremes of age (e.g., among persons 65 years and older and children 
under 2 years of age) and persons with certain medical conditions. In the 
United States, an average epidemic season of influenza results in more 
than 36,000 deaths and 200,000 hospitalizations due to influenza-related 
causes (CDC, 2009c). Among influenza-related deaths, most of the ex-
cess mortality occurs in persons 65 years and older, often from pneumo-
nia (Lewis, 2006).  
Copyright © National Academy of Sciences. All rights reserved.
Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A: A Letter Report
http://www.nap.edu/catalog/12748.html
12 RESPIRATORY PROTECTION FOR HEALTHCARE WORKERS 
 
Influenza viruses are RNA viruses with a segmented genome. Two 
influenza A virus subtypes and one influenza B virus have been circulat-
ing since 1977, and winter peaks are typically seen. Seasonal influenza 
viruses mutate frequently and this antigenic drift is the reason why vac-
cine formulations are changed annually. Current seasonal influenza vi-
ruses consist of an H1N1 and an H3N2 subtype (subtypes are classified 
by the surface proteins of the virus called hemagglutinin [H] and neura-
minidase [N]). In addition, a novel H1N1 influenza A virus (nH1N1) 
appeared in 2009. Thus, four different influenza virus strains (two H1N1, 
one H3N2, and one B virus) are currently circulating (CDC, 2009b; Fiore 
et al., 2009).  
Over the past 400 years at least 31 pandemics have been described; 
during the 20th century, pandemics occurred in 1918 (H1N1), in 1957 
(H2N2) and in 1968 (H3N2) (Lazzari and Stohr, 2004). In contrast to 
influenza epidemics, pandemics occur more rarely, every 10 to 50 years 
(Kamps and Reyes-Terán, 2006). Of the three recent pandemics, the 
1918 pandemic resulted in the highest mortality, causing an estimated 
675,000 deaths in the United States and a total of 50 million or more 
deaths worldwide (HHS, 2009). In 1977, an H1N1 virus reappeared after 
a hiatus of 20 years without displacing the H2N2 strain. At that time, 
many young people under 23 years of age had no immunity to H1N1 vi-
ruses and that age group was preferentially affected by influenza virus 
infections with strains of that subtype (HHS, 2009).  
 
 




In 2009, a novel influenza A (nH1N1) virus was detected among 
humans in Mexico in March 2009 and the first two cases of nH1N1 were 
identified in the United States in April 2009 (CDC, 2009j). The virus is a 
triple-reassortant influenza A (H1) of human, swine, and fowl origins 
from North America (Shinde et al., 2009). Since then the virus has 
spread worldwide and 71 percent of the circulating influenza is attribut-
able to this strain (Olsen, 2009). The WHO declared an nH1N1 pan-
demic on June 11, 2009. As of August 13, 2009, 177 countries and 
overseas territories and communities have reported over 180,000 labora-
tory confirmed cases of nH1N1, with the majority of cases occurring in 
the Americas (WHO, 2009b). Over 1,799 deaths have been reported 
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worldwide. In the United States, 7,983 hospitalizations and 522 deaths 
associated with nH1N1 were reported to CDC as of August 21, 2009 
(CDC, 2009a). Because relatively few people with respiratory illnesses 
are tested for nH1N1 infection and countries are no longer required to 
test and report individual cases, these numbers likely underestimate the 
true impact of this pandemic. This is particularly the case in determining 
the overall prevalence of infection and therefore determining the de-
nominator for any calculation of mortality and morbidity rates.  
Novel H1N1 has emerged as the primary influenza virus in the 
Southern Hemisphere and in countries such as Australia, certain prov-
inces have reported increased numbers of cases, increased emergency 
department volume, and increased illness severity (Australian Depart-
ment of Health and Ageing, 2009). Summary data from earlier in the 
outbreak show the crude hospitalization ratios ranging from 3.4 to 8.9, 




Spectrum of Illness 
 
The spectrum of illness associated with nH1N1 is similar to that re-
ported with seasonal influenza infection varying from asymptomatic to 
mildly symptomatic to severely ill. Most infected individuals exhibit 
mild, self-limiting influenza-like symptoms including fever, lethargy, 
and loss of appetite (see Table 2). Of note, diarrhea is reported as com-
mon to nH1N1 infection while it is uncommon to seasonal influenza 
(Levine, 2009). Severe complications of influenza that have been re-
ported in patients with nH1N1 include primary influenza pneumonia, 
secondary bacterial pneumonias, adult respiratory distress syndrome, and 
encephalopathy (children) (CDC, 2009g). To date, a small number of 
cases of viral resistance to oseltamivir (Tamiflu) have been reported and 
the virus appears to remain sensitive to zanamivir (Relenza) at this time 
(WHO, 2009b).  
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Fever No/rare Common/high Common/high Common/high 
Malaise No Yes Yes Yes 
Myalgias No Yes Yes Yes 
Rhinorrhea Copious Mild Mild Mild 
Cough No Common Common Common 






Diarrhea No Uncommon Common Common 
Morbidity 
(bed rest) 
Rarely Common Common Common 
Fatalities No Elderly, very 
young, those with 
underlying illness 
All groups but 
predominance in 
< 50 years 
Ages 25–49 
SOURCE: Levine, 2009; Perez-Padilla et al., 2009.  
 
 
Populations at Risk 
 
Specific populations seemingly at higher risk for nH1N1 inflection 
include children and young adults, pregnant women, and those with 
chronic illnesses and immunocompromised states (CDC, 2009d; Fiore, 
2009). nH1N1 influenza differs from seasonal influenza most notably in 
terms of the ages of the populations at highest risk. Case rates are highest 
in individuals less than 49 years old (see Table 3). For seasonal influ-
enza, persons 65 years and older account for 60 percent of influenza-
related hospitalizations as compared to 5 percent of nH1N1 related hos-
pitalizations. In addition, 8 percent of nH1N1-related deaths occurred 
among persons 65 years and older compared to 90 percent of seasonal 
influenza-related deaths (National Center for Immunization and Respira-
tory Diseases, 2009). As of July 2009, the median age for individuals 
hospitalized with laboratory-confirmed nH1N1 was 20 years and the me-
dian age of individuals who died with nH1N1 infection was 37 years.  
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TABLE 3 Case Rate and Hospitalization Rate per 100,000  
Population by Age Group of Laboratory-Confirmed nH1N1  
in the United States 
Age (years) Case Rate Hospitalization Rate 
0–4 22.9 4.5 
5–24 26.7 2.1 
25–49 6.97 1.1 
50–64 3.92 1.2 
≥ 65 1.3 1.7 





Review of data regarding the epidemiology of nH1N1 influenza in 
the United States and in countries in the Southern Hemisphere indicates 
no antigenic change thus far in the virus and does not suggest any major 
change in virulence. The committee heard testimony about specific popu-
lations in intensive care units with high mortality in both the United 
States and Australia. However, the aggregate data at this time do not 
demonstrate mortality more excessive than with seasonal influenza. The 
interpretation of the data however is subject to variability dependent 
upon the ascertainment of the total number of infected individuals and 
deaths. The U.S. experience at the present time is limited to a spring and 
summer outbreak, not the usual time for influenza, and therefore does not 
provide the complete view of the potential impact of nH1N1. It is impor-
tant to note that CDC has stopped collecting information on individual 
nH1N1 cases. 
Current evidence indicates that the nH1N1 virus does not contain 
specific genes thought to contribute to virulence in humans that have 
been present in some other pandemic strains. However, it is a novel virus 
that enters populations in which many members, particularly younger 
people and children, have no previous immunity to its antigens. It is this 
lack of immunity that makes the younger population so susceptible to 
infection, morbidity, and mortality. This is in contrast to other seasonal 
influenza strains that have particularly affected elderly and very young 
individuals. Younger healthcare workers will be particularly susceptible 
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INFLUENZA TRANSMISSION  
 
Human transmission of influenza virus is thought to primarily occur 
by three routes: (1) contact exposure in which the virus is transferred by 
direct physical contact between an infected and uninfected individual or 
indirectly through fomites (contaminated objects or surfaces) and subse-
quent hand to face contact; (2) droplet spray exposure through the direct 
projection by coughing or sneezing of respiratory fluid particles with 
diameters greater than 100 μm; and (3) airborne (inhalation) exposure. 
Because large droplets settle rapidly from air, exposure to droplet spray 
requires close contact with the influenza patient; for airborne exposure 
the virus is carried both on smaller respirable4,5 particles that can pene-
trate to and deposit in the alveolar region and inhalable particles that de-
posit in the tracheobronchial and nasopharyngeal airway regions. With 
most respiratory pathogens, including influenza, the relative contribution 
of each of these types of transmission has not been adequately ascer-
tained. Adding to the uncertainty, the respective proportions may vary 
with the setting, with the temperature and humidity, with the intensity of 
virus emission, and with infectivity of the virus (the probability of infec-
tion per virus) when received via different exposure routes (Nicas and 
Jones, 2009). Data are limited on the distances that respiratory fluid par-
ticles of various sizes travel through the air before settling. Further, even 
for a single particle size, the distance traveled is expected to vary with 
the force of the expiratory event, the angle of emission relative to the 
floor, and air turbulence conditions. 
Future studies may have difficulty quantifying the relative impor-
tance of each potential route of transmission, especially due to limita-
tions with controlled human experiments. Consequently, mathematical 
modeling and analysis have the potential to improve knowledge of hu-
man-to-human transmission of influenza virus. In this vein, mathematical 
 
4Respirable particles include both the small particles associated with coughing, sneez-
ing, and breathing as well as the larger particles which dessicate into smaller particles 
known as droplet nuclei. 
5The committee used the standardized categorization regarding particle size and depo-
sition: inhalable (particles inhaled through the nose and/or mouth during breathing), tho-
racic (the subfraction of inhalable which penetrates into the lung below the larynx), and 
respirable (the subfraction of inhalable which penetrates down to the alveolar region).  
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models have been developed to help estimate the relative contribution of 
each exposure pathway. These models consider the existing knowledge 
base regarding virus concentrations, frequency and size of particles gen-
erated in coughs and sneezes, gravitational and decay characteristics of 
these particles, and role of humidity and ventilation. Nicas and Jones 
found “influenza A transmission in natural settings may involve multiple 
exposure pathways, although the relative contribution of each pathway is 
situation-specific and depends on a set of factors that will be unknown a 
priori” (Nicas and Jones, 2009). They therefore concluded that non-
pharmaceutical interventions for pandemic virus must address all poten-
tial routes of exposure. In contrast, Atkinson and Wein found aerosol 
transmission to be more dominant than contact transmission (Atkinson 
and Wein, 2009). 
This letter report is focused solely on airborne exposures that would 
require respiratory protection. Respirable particles settle slowly from air 
and are able to disperse throughout the room. Thus, inhalation exposure 
to respirable particles does not require close contact with an influenza 
patient, although exposure intensity is higher close to the patient. Large 
droplet particles settle more rapidly from air and do not disperse 
throughout the room. Thus, exposure to these particles tends to require 
close contact with the influenza patient, although there is a continuum of 
distances traveled from the point of emission depending on particle size.  
Evidence from environmental and animal studies has supported the 
role of airborne exposure in the transmission of influenza virus. The 
2008 IOM report reviewed research on airborne transmission including 
animal studies on influenza transmission and observational studies on the 
effects of ultraviolet light and air circulation (IOM, 2008b). Newer stud-
ies published since the 2008 IOM report provide additional evidence re-
garding airborne transmission. For example, Fabian and colleagues 
(2008) showed that persons ill with influenza A (and B) emit the virus as 
respirable-size particles in exhaled breath and in coughs. In a study using 
stationary and personal sampling and measurement in a healthcare clinic 
attended by patients with influenza A (and B), researchers confirmed the 
presence of the airborne influenza virus in various clinic locations and in 
the breathing zones of healthcare workers, with more than fifty percent 
of detectable virus particles in the respirable range (Blachere et al., 
2009). Mubareka and colleagues (2009) found that guinea pigs infected 
with the influenza A virus (H3N2) can efficiently transmit the infection 
to susceptible guinea pigs via inhalation, presumably by virus carried on 
respirable particles (Mubareka et al., 2009). Other recent studies show 
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that ferrets infected with nH1N1 virus transmitted the infection to sus-
ceptible animals via inhalation. Inhalation transmission was less efficient 
compared to a seasonal H1N1 virus in the study by Maines and col-
leagues (2009) but was found to be efficient in the second study (Mun-
ster et al., 2009).  
Current evidence supports airborne exposure as likely being one of 
the routes of nH1N1 virus transmission in healthcare settings absent ap-
propriate exposure control measures. This does not preclude transmission 
by the droplet spray and contact routes absent appropriate control meas-
ures. Therefore, the committee concluded that recent animal and envi-
ronmental studies have demonstrated the importance of airborne 
transmission of nH1N1 virus; however, the relative contribution of each 
of the possible routes of transmission is yet to be determined. Without 
knowing the contributions of each of the possible route(s) of transmis-




FOR HEALTHCARE WORKERS 
 
Although much remains to be learned about the routes of nH1N1 
transmission and about which medical procedures and types of interac-
tions will result in high-risk exposures to healthcare workers, the virus is 
known to pose hazards in healthcare facilities and to healthcare workers 
because of its short incubation period, patient infectivity prior to clinical 
symptoms, variability of viral shedding among different hosts, multiple 
routes of transmission, and efficient spread from person to person. While 
it is widely assumed that aerosol-generating procedures increase the ex-
posure risk to healthcare workers, data about procedural risks are cur-
rently lacking. Nevertheless, there is evidence that work-related 
exposures to patients infected with nH1N1 virus result in healthcare 
workers becoming infected (CDC, 2009h; Perez-Padilla et al., 2009). 
More needs to be learned about the significance and impact of transmis-
sion of influenza in a variety of healthcare settings.  
Several patient populations would be of particular concern during an 
nH1N1pandemic, and their care may pose increased risk of exposure to 
healthcare workers. Prevalence appears highest in children, youth, and 
young adults, the latter group being part of the healthcare workforce. 
Healthcare workers may be hesitant to come to work during a pandemic 
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if they do not feel adequately protected and confident in the facility’s 
ability to safely meet demands for patient care (Irvin et al., 2008). 
Under the Occupational Safety and Health Act, employers are re-
quired to provide a workplace free from recognized hazards and to take 
feasible steps to protect workers from those hazards (Public Law 91-
596). Healthcare organizations and workers need consistent and clear 
nH1N1 guidelines that can be implemented across all healthcare facili-
ties. In addition, employers must devote significant effort to assessing 
risk in their organization and to fully implementing those guidelines so 
needed practices are widely adopted. This should include ongoing educa-
tion and training of healthcare workers. Employers should make special 
efforts to provide a place where workers can get questions answered and 
concerns addressed. Worker adherence and protection can be enhanced if 
individuals believe that the guidelines are derived from the best available 
evidence. 
Although workers are aware of expert guidance and the risk they 
face, they often do not wear PPE when faced with conditions requiring 
its use. Such noncompliance is also seen in low rates of hand hygiene 
and use of gloves, respirators, and eye protection. To improve the com-
pliance rates and thereby improve worker protection, a “culture of 
safety” for workers must be established in all healthcare organizations 
evidenced by senior leadership commitment. America’s healthcare insti-
tutions need to create, foster, and act as a role model of a culture of 
worker safety that is akin to the commitment made to patient safety. This 
culture of worker safety will require an emphasis on planning, education, 
equipment, materials, organization, bed spacing, patient isolation, and 
many other factors that focus on maximizing worker and patient safety. 
Employees should feel uncomfortable when not wearing PPE during ap-
propriate situations, and supervisors should reinforce the importance of 
PPE and enforce policies so that noncompliance is a rare exception rather 
than the rule (IOM, 2008b). 
The committee heard testimony that strong institutional commit-
ments to safety may minimize absenteeism, particularly during a pan-
demic, although available data, particularly from the SARS (severe acute 
respiratory syndrome) experience suggest that healthcare workers are 
highly motivated to come to work in the face of uncertain risk when they 
believe that their contributions to patient care are critical and that they 
will be protected. It is recognized that such actions will not prevent 
healthcare workers from becoming infected in the community through 
activities unrelated to their jobs. 
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EFFICACY OF RESPIRATORS AND MEDICAL MASKS 
 
The two major issues with regard to assessing the efficacy of respira-
tory protection measures are the effectiveness of the filter and the extent 
to which the respirator has a tight seal with the wearer’s face that re-
stricts inward leakage. Respirators are personal protective devices that 
cover the nose and mouth (or in some cases, more of the face and head) 
and operate either by purifying the air inhaled by the wearer through fil-
tering materials or by independently supplying breathable air to the 
wearer. To be optimally effective, most types of respirators require a 
tight facial seal, thus individual fit testing is required.  
In the healthcare setting, medical masks are loose-fitting facial cov-
erings that are designed to prevent wound contamination in the patient 
from the cough or exhaled secretions of the physician, nurse, or other 
healthcare worker. As noted in the 2008 IOM report, medical masks are 
not designed or certified to protect the wearer from exposure to airborne 
hazards (IOM, 2008b). They may offer some limited, as yet largely unde-
fined, protection as a barrier to splashes and droplet spray. However, be-
cause of the loose-fitting design of medical masks (and consequent 
leakage around the sides) and their lack of protective engineering, medi-
cal masks are not considered personal respiratory protective equipment. 
Both respirators and medical masks may act as a barrier to the spread of 
droplets and to contact transmission that might occur when hands touch 
the nose or mouth, but the committee did not examine these routes of 
exposure.  
The National Institute for Occupational Safety and Health (NIOSH) 
certifies the filtering performance of respirators,6 but the Food and Drug 
Administration (FDA) has no similar certification process for medical 
masks. Healthcare facilities are required to purchase NIOSH-certified 
respirators to comply with OSHA regulations when protecting workers 
against inhalation of airborne hazards. FDA examines submissions of 
data on medical masks and can provide market clearance for medical 
masks. There are no regulatory requirements for healthcare facilities ne-
cessitating purchase of FDA-cleared medical masks.  
Recent studies have strengthened the evidence that respirators afford 
greater protection against respirable particles than medical masks. Stud-
ies comparing the filtering efficacy of medical masks and certified N95 
 
6N95 respirators cleared by FDA for use in the healthcare setting are called surgical 
N95 respirators. These devices are also NIOSH certified to meet the N95 respirator per-
formance requirements (FDA, 2009).  
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respirators have found consistently high filtering capacity of N95 respira-
tors and a wide range of filtering performance by medical masks (Qian et 
al., 1998; Oberg and Brosseau, 2008; Rengasamy et al., 2008, 2009). 
N95 respirators are tested as part of the NIOSH certification process to 
determine if they meet the criteria to filter out at least 95 percent of parti-
cles that are 0.3 µm in size (42 CFR Part 84). Studies by Lee and col-
leagues (2008) and Balazy and colleagues (2006) used aerosols of similar 
particle size range to bacteria and viruses (0.04–1.3 µm) and found that 
while some N95 respirators allowed slightly greater than 5 percent parti-
cle penetration, they had protection factors that were 8 to 12 times 
greater than those of medical masks. A recent study of nine types of 
medical masks by Oberg and Brosseau (2008) found wide variations in 
particle penetration (4 percent to 90 percent) through medical mask fil-
ters. The study also found that the majority of the medical masks failed 
the qualitative fit tests and all failed the quantitative fit tests. At the 
workshop, discussion focused on filtration principles that show that the 
aerodynamic behavior of an aerosol particle is based on its size, density, 
and shape (i.e., a 0.3 µm latex sphere behaves in a similar manner to a 
particle of the same size, density, and shape that may carry a virus).  
Using particles less than 1 µm, a study of total leakage through 
medical masks worn by 25 subjects found that the contribution to total 
leakage into the medical mask was 5 percent to 8 percent from filter 
leakage and 25 to 38 percent from faceseal leakage (Grinshpun et al., 
2009). In that study, N95 respirator contribution to total leakage was 
less than 1 percent from filter leakage and 3 to 5 percent from faceseal 
leakage.  
One of the important issues in the discussion of medical masks ver-
sus respirators has been the issue of comfort and wearability. A study on 
worker tolerance for wearing respiratory protective devices over the 
course of an 8-hour work shift demonstrated that a variety of medical 
masks and respirators (N95 filtering facepiece, elastomerics, and pow-
ered air-purifying respirators) were all poorly tolerated (Radonovich et 
al., 2009b). The study noted the progressive decline over the workday in 
the utilization of medical masks, N95 respirators, and powered air-
purifying respirators with not more than 30 percent of workers wearing 
these devices throughout the 8-hour working day. A range of issues was 
reported including discomfort, difficulty speaking and communicating, 
and a number of physical complaints. A federal interagency effort (Pro-
ject BREATHE—Better Respirator Equipment Using Advanced 
Technologies for Healthcare Employees) is focused on specifying per-
Copyright © National Academy of Sciences. All rights reserved.
Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A: A Letter Report
http://www.nap.edu/catalog/12748.html
22 RESPIRATORY PROTECTION FOR HEALTHCARE WORKERS 
 
                                                                
formance criteria for improvements in respirators for healthcare workers 
(Radonovich et al., 2009a).  
Data are quite limited that could inform decisions regarding other 
types of respirators that healthcare workers should be provided. Despite 
the apparent differences in filtering efficiency (95 percent, 99 percent, 
and 100 percent), all tight fitting half-face negative pressure air purifying 
respirators (including filtering facepiece respirators like N95s, N99s and 
P100s, along with all half-mask elastomeric respirators equipped with 
either N95, N99, and P100 filter cartridges) are assigned the same pro-
tection factor7 by OSHA. NIOSH-certified respirators with N95 filters 
will filter between 95 and 99 percent of the most penetrating aerosols 
(0.3 µm). Further, as with N95 respirators, the majority of particle pene-
tration in the N99 and P100 respirators comes from facepiece leakage. 
The committee did not identify any data from clinical trials comparing 
the efficacy of N95 respirators to that of N99 or other respirators with 
superior filtering efficacy and similarly did not find comparisons of res-
pirator protection during various clinical procedures including aerosol-
generating procedures. Some healthcare facilities have used respiratory 
protection devices with higher levels of protection, such as powered air 
purifying respirators, during aerosol generating procedures. 
Current CDC guidelines and OSHA requirements both indicate that 
fit testing is required when using an N95 respirator. The committee re-
viewed evidence that while some medical masks have filter efficiencies 
that approach N95 respirators, the major difference is that they do not 
make a tight seal to the face. The purposes of fit testing are to ensure a 
properly fitted respirator that minimizes facepiece leakage and to provide 
the user with education on how to maintain a tight seal of a respirator 
essential for efficacious function. As discussed in the 2008 IOM report, 
ongoing research is needed to standardize fit test methodologies and to 
develop technologies for the production of more effective and consistent 
faceseals for respirators (IOM, 2008b). 
Ongoing efforts are exploring a number of design and reusability is-
sues associated with the use of medical masks and respirators. NIOSH is 
proposing the addition of tests of total inward leakage for filtering 
facepiece respirators to the respirator certification process. An additional 
issue noted by the committee was the need for clear and consumer-
friendly measures to permit comparison of the characteristics and testing 
 
7For this type of respirator, the assigned protection factor is 10, a measure of the ratio 
of the concentration of the contaminant outside the respirator to the concentration of the 
contaminant inside the respirator.  
Copyright © National Academy of Sciences. All rights reserved.
Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A: A Letter Report
http://www.nap.edu/catalog/12748.html
LETTER REPORT 23 
 
data on respirators. If testing data of a similar rigorous nature becomes 
available for medical masks, then consumer-oriented approaches to dis-
seminating that data would also be beneficial.  
Although this report is focused on studies relevant to healthy health-
care workers wearing a medical mask or respirator to prevent the devel-
opment of influenza, it is important to note that there are data in a small 
number of studies that support the effectiveness of medical masks and 
respirators as source control (i.e., worn by patients) to prevent transmis-
sion from ill patients to healthcare workers or other patients (Inouye et 
al., 2006; Johnson et al., 2009). Medical masks for source control may 
decrease transmission occurring through droplets and other larger parti-
cles or materials, although not significantly decreasing airborne trans-
mission. Further research on their use in patients is needed. 
 
 
CLINICAL STUDIES OF MEDICAL MASKS 
AND RESPIRATOR USE IN PREVENTING 
RESPIRATORY DISEASE 
 
Few data are available on the clinical effectiveness of medical masks 
and respirators in preventing the transmission of respiratory disease vi-
ruses; thus, this is an area needing further research. The 2008 IOM study 
examined studies on the use of respirators and medical masks in prevent-
ing respiratory syncytial virus transmission and transmission of SARS 
(severe acute respiratory syndrome) and found mixed results (IOM, 
2008b). Recent reviews of physical interventions to prevent or slow the 
spread of respiratory viruses have noted the limited state of clinical evi-
dence on comparison of medical masks and N95 respirators and the ab-
sence of randomized controlled clinical trials (Jefferson et al., 2008; Lee 
and Umscheid, 2009). Observational studies on the use of medical masks 
have noted reductions in respiratory disease outbreaks in which medical 
masks were used as one part of a set of interventions (Weinstock et al., 
2000; Jefferson et al., 2008); however, conclusions cannot be drawn as 
the effects of PPE cannot be separated from the confounding effects of 
other infection control measures. A recent study of the 2009 outbreak of 
nH1N1 in Mexico reported that after the strict enforcement of infection 
control measures (e.g., patient isolation; use of N95 respirators, goggles, 
gowns, and gloves; liberal use of hand sanitizer) in hospitals treating pa-
tients with the nH1N1 virus, no additional healthcare workers contracted 
influenza-like illness (Perez-Padilla et al., 2009) . 
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The committee found that several studies are being reviewed that 
might provide additional insights into questions regarding respiratory 
protection and influenza transmission. Information on these studies was 
available through conference abstracts or presentations at the workshop. 
A community study by Aiello and colleagues focused on college students 
living in dormitories who were randomized to wear medical masks only 
or to use hand hygiene plus medical masks during two winter seasonal 
influenza seasons. In year 1, both intervention groups showed reduced 
influenza-like illness versus controls. In year 2, the group using medical 
masks and hand hygiene had reductions in PCR-positive influenza 
(Aiello and Monto, 2009). Cowling and colleagues in a recently pub-
lished paper described a randomized trial that assessed secondary infec-
tions in families with a single index child ill with influenza (Cowling et 
al., 2009). In a subset of the households, those where the intervention 
was started within 36 hours of initial symptoms in the index patient, a 
reduction in infections for those using medical masks and hand hygiene 
was noted. However, because the index case was also encouraged to 
wear a medical mask, one cannot discern a protective effect of the medi-
cal mask as a personal protective device versus its role in source control. 
A cluster-randomized clinical trial in a community setting examined use 
of P2 respirators (similar to N95 respirators) and medical masks worn by 
well parents of a child sick with an influenza-like illness (MacIntyre et 
al., 2009a). This study showed no effect by intention-to-treat analysis but 
a reduction in risk of infection by 60 to 80 percent in subjects with either 
medical mask or respirator use was noted. The study was not powered to 
examine the difference between medical masks and P2 respirators and 
the effect was seen for all devices combined.  
Two studies in healthcare workers are submitted for publication. 
MacIntyre and colleagues (2009b) conducted a cluster randomized clini-
cal trial to compare the clinical efficacy of medical masks versus N95 
respirators with and without fit testing, versus control in influenza trans-
mission in 1,936 healthcare workers in China. N95 respirators were 
found to have statistically significant efficacy of 60 percent against clini-
cal respiratory illness, 75 percent against influenza-like illness, 56 per-
cent against laboratory-confirmed respiratory viral infection, and 75 
percent against confirmed influenza. Medical masks showed no efficacy. 
In a randomized trial in Canada of 446 individual nurses working in 
acute care institutions randomized to fit tested N95 respirators versus 
masks during the 2008–2009 influenza season, medical masks were 
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found to be noninferior to the respirators.8 However, without having the 
full details of the studies the committee could not draw conclusions from 
either study. Clinical effectiveness data are thus quite limited and con-
flicting at this time, and the committee in its recommendations urges fur-
ther randomized clinical trials be conducted to explore the types and 
combinations of PPE that will be effective as one component of strate-
gies to prevent influenza transmission in healthcare workers.  
 
 
FACTORS IN DECISIONS 
ON RESPIRATORY PROTECTION  
 
At its workshop the committee heard several perspectives on deci-
sion-making strategies all of which emphasized the importance of focus-
ing on the hierarchy of controls in ensuring a safe work environment. 
Rather than focusing to such a large extent on PPE that is subject to 
variations in individual use, the speakers urged environmental and ad-
ministrative strategies to minimize the number of healthcare workers 
(and patients) potentially exposed to nH1N1, such as innovative triage 
approaches and cohorting. In general, a risk management approach is 
used in infection control that focuses on identifying the hazard, assessing 
the risk, mitigating the risk through appropriate interventions, and subse-
quently monitoring and reviewing the effect of the interventions in two 
constituent groups—patients and healthcare workers. The degree of pro-
tection or the choice of PPE is determined by the degree of risk to the 
healthcare worker (OSHA, 2009). Based on its expert judgment, the 
committee identified a number of factors that affect the degree of risk 
including the characteristics of the virus, the healthcare worker’s condi-
tion, the work environment, the patient’s condition, and the patient–
worker encounter (see Box 2).  
In examining the many issues regarding selecting the appropriate 
personal protection for healthcare workers exposed to nH1N1, the com-
mittee recognized the breadth and importance of issues that factor into 
these decisions and the many questions that remain largely unknown. 
The committee was tasked with examining the factors related to the 
 
 
8Personal communication with M. Loeb, McMaster University, August 20, 2009. 
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transmission of the virus and the efficacy of personal respiratory protec-
tive technologies, but it was not tasked with considering the economic 
and logistical implications, the extent of healthcare workers’ individual 





Risk Factors and Issues That Affect PPE Decisions 
 
Virus Characteristics:  
 • Nature of the hazard—virulence, disease severity, lethality, life (longevity) 
 • Routes of transmission 
 • Ease of transmission 
 
The Healthcare Worker: 
 • Natural immunity and immunization status 
 • Age  
 • Underlying health conditions 
 • Personal risk factors (e.g., chronic diseases and personal habits) 
 • Immunoprophylaxis 
 • Compliance with PPE 
 
Work Environment:  
 • Setting (e.g., hospital, emergency medical services, direct care) 
 • Volume of patients 
 • Source control 
 • Ambient conditions 
 • Virus load profile 
 • PPE comfort and wearability 
 • Isolation, cohorting, and other environmental and administrative controls 
 
The Patient: 
 • Age  
 • Super-shedder, super-spreader 
 • Underlying health conditions/symptoms 
 • Personal risk factors (e.g., chronic diseases and habits) 
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On the basis of input from the IOM workshop, previous IOM reports, 
the expert judgment of the committee members, and review of the litera-





The committee’s task focused solely on personal respiratory protec-
tion. Studies on influenza transmission show that airborne transmission is 
one of the potential routes of transmission. Research is needed to deter-
mine the relative contribution of the transmission pathways. Given the 
limited information on routes of transmission, the committee found that 
respiratory protection is indicated at this time.  
Evidence from NIOSH staff and other researchers provide convinc-
ing data on the ability of N95 respirators to filter out 95 to 99 percent of 
relevant particles and these devices have their maximum effectiveness 
when properly fitted to the face of users. Research results on the filtra-
tion and fit of medical masks show wide variation in penetration of aero-
sol particles (4 percent to 90 percent) suggesting that the use of many of 
these masks is unlikely to be effective to protect against airborne trans-
mission. Additionally, there was considerable evidence in laboratory 
studies of an order of magnitude higher leakage of particles under and 
around the medical mask from the unfitted margins than respirators. 
However, it is important to note that controversy exists regarding clinical 
guideline decision making in regards to the clinical effectiveness of 
medical masks. That is, some experts assert that factors including worker 
compliance may significantly affect the clinical effectiveness of various 
personal respiratory protection technologies and therefore have implica-
tions for appropriate clinical guidelines. The committee found a paucity 
of studies on the clinical effectiveness of respirators versus medical 
masks for influenza. Several studies are underway or in publication. The 
few studies available in abstract form or presented at the conference 
showed mixed results. The committee bases its recommendation on the 
evidence of airborne transmission and the filtering and fit characteristics 
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Recommendation 1: Use Fit-Tested N95 Respirators 
Healthcare workers (including those in non-hospital settings) 
who are in close contact with individuals with nH1N1 influ-
enza or influenza-like illnesses should use fit-tested N95 respi-
rators or respirators that are demonstrably more effective as 
one measure in the continuum of safety and infection control 
efforts to reduce the risk of infection.  
• The committee endorses the current CDC guidelines 
and recommends that these guidelines should be con-
tinued until or unless further evidence can be provided 
to the effect that other forms of protection or other 
guidelines are equally or more effective.  
• Employers should ensure that the use and fit testing of 
N95 respirators be in accordance with OSHA regula-
tions, and healthcare workers should use the equip-
ment as required by regulations and employer policies. 
 
The committee acknowledges that many issues factor into the policy 
decision-making process and notes in the recommendation that the 
guidelines will need to be subsequently reexamined as is generally done 
for many forms of clinical guidance. It is not the intention of the commit-
tee to recommend that all healthcare workers use N95 respirators, rather 
the use of respirators should be for those in initial contact with individu-
als presenting with undetermined febrile respiratory illnesses or those 
with close contact with individuals with confirmed or suspected nH1N1. 
The term close contact has generally been defined as being within 6 feet 
of a patient (CDC, 2009i). In addition, the entrance of a healthcare 
worker into an enclosed space with a patient (e.g., isolation rooms) has 
also been identified to pose a higher risk for infection of healthcare 
workers. However, the committee concluded that there was insufficient 
evidence at this time to fully define close contact for all settings and 
situations. 
As noted throughout this report, respiratory protection is one part 
of a systematic multipronged infection prevention and control strategy. 
The goal is to minimize risk and decrease the number of healthcare 
workers with potential exposure to undetermined febrile respiratory ill-
nesses and to accurately and rapidly diagnose patients who necessitate 
antivirals, antimicrobials, and other essential medical and public health 
interventions.  
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It is still unclear what proportion of the spread of influenza virus oc-
curs through each of the potential routes of transmission (contact, droplet 
spray, airborne), as well as the role of respiratory protection devices for 
each of these routes of transmission. Because of the lack of a strong and 
conclusive evidence base, the committee noted that determination of the 
relative contribution of each route of transmission is essential for long-
term preparedness planning. Secondly, the committee concluded that a 
stronger evidence base is needed regarding the effectiveness of personal 
respiratory protection technologies in clinical settings. As described pre-
viously, while some data are available, more research is needed to under-
stand the clinical implementation of efficacious technologies, such as 
how compliance with various technologies can affect their use. Finally, 
as suggested in the IOM 2008 report (IOM, 2008b), continued collabora-
tion and integration between the relevant agencies (e.g., FDA, CDC) are 
essential to assure the clinical implementation of newer technologies that 
are both efficacious as well as effective in the clinical setting. The com-
mittee bases the following recommendation on its examination of the 
evidence base, workshop presentations on the newest studies available, 
previous IOM studies, and its expert judgment. 
 
Recommendation 2: Increase Research on Influenza Trans-
mission and Personal Respiratory Protection 
CDC centers (e.g., National Institute for Occupational Safety 
and Health; National Center for Immunization and Respira-
tory Diseases; National Center for Preparedness, Detection, 
and Control of Infectious Diseases), the National Institutes of 
Health, and other relevant federal agencies and private insti-
tutions should fund and undertake additional research to  
• resolve the unanswered questions regarding the rela-
tive contribution of various routes of influenza trans-
mission,  
• fully explore the effectiveness of personal respiratory 
protection technologies in a variety of clinical settings 
through randomized clinical trials, and 
• design and develop the next generation of personal 
respiratory protection technologies for healthcare 
workers to enhance safety, comfort, and ability to per-
form work-related tasks.  
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INSTITUTE OF MEDICINE 
Board on Health Sciences Policy 
 
Respiratory Protection for Healthcare Workers in the Workplace 
Against Novel H1N1 Influenza A 
 
August 11–13, 2009 
National Academy of Sciences Building  
2100 C Street, NW 
Washington, DC 
 





SPONSOR CHARGE TO THE COMMITTEE 
 
3:30–3:45 p.m. Welcome and Introductions 
  Kenneth Shine, Chair 
  Bonnie Rogers, Vice Chair 
 
3:45–4:15 Charge to the Committee  
Dixie Snider, Centers for Disease Control 
 and Prevention 
Jordan Barab, Occupational Safety and Health 
 Administration 
 
4:15–5:00 Discussion with the Sponsors 
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Wednesday, August 12, 2009 
Lecture Room 
8:00 a.m.–5:00 p.m. 
 
INSTITUTE OF MEDICINE 
Workshop on Personal Protective Equipment  
for Healthcare Workers in the Workplace Against  
Novel H1N1 Influenza A 
 
Workshop Goals 
• Examine the emerging science and clinical experience base 
associated with nH1N1. 
• Discuss criteria used to delineate infection control guidelines. 
• Discuss criteria used to assess risk to the healthcare workforce.  
• Examine what’s known about the effectiveness of medical masks, 
respirators, gowns, gloves, and eye protection in preventing nH1N1 




7:30–8:00 a.m. Registration and Continental Breakfast 
 
8:00–8:15 Welcome, Introductions, and Opening Remarks 
Kenneth Shine, Chair 
Bonnie Rogers, Vice Chair 
 
8:15–8:45 Study Background and Current Guidelines 
Toby Merlin, Centers for Disease Control and 
Prevention 
Rosemary Sokas, Occupational Safety and Health 
Administration 
 
8:45–10:00 Panel 1: nH1N1 Influenza A  
Current Findings, Unique Characteristics, 
and Potential Future Implications 
Moderator: Kenneth Shine 
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Objectives:  
• Examine current criteria used to characterize the 
influenza virus including transmissibility, virulence, 
and lethality; discuss the potential for future changes 
in severity and virulence. 
• Discuss current clinical experience with nH1N1.  
 
8:45–9:30 Panel Presentations 
• Overview of H1N1 
 Myron Levine, University of  
  Maryland School of Medicine 
• Southern Hemisphere Perspective 
 Sonja Olsen, Centers for Disease 
  Control and Prevention 
• U.S. Clinical Experience 
Russell Miller, Intermountain 
Medical Center and University of 
Utah (via phone) 
 
9:30–10:00 General Discussion 
  
10:00–11:30 Panel 2: Influenza Transmission  
Moderator: Bonnie Rogers 
 
Objective:  
• Examine clinical and experimental research on 
influenza transmission. 
 
10:00–11:00 Panel Presentations 
• Introduction—Donald Milton, 
University of Maryland 
• Peter Palese, Mount Sinai School 
 of Medicine 
• Bill Lindsley, National Institute for 
Occupational Safety and Health   
• James McDevitt, Harvard 
 University 
• Overview and Summary 
 Donald Milton, University of 
  Maryland  
11:00–11:30 General Discussion 
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11:30 a.m.–12:15 p.m. LUNCH 
  
12:15–2:00 Panel 3: Preventing Influenza Transmission with 
Personal Protective Equipment: Clinical 
and Community Studies 
   Moderator: Tia Powell 
 
Objective:  
• Examine studies on use of personal 
protective equipment in preventing 
influenza transmission. 
 
12:15–1:30 Panel Presentations 
• Allison Aiello, University of 
Michigan (via phone) 
• Raina MacIntyre, University of New 
South Wales  
• Ben Cowling, University of Hong 
Kong (via phone)  
• Paul Ananth Tambyah, University of 
Singapore (via phone) 
  
1:30–2:00 General Discussion  
 
2:00–2:15  BREAK 
 
2:15–4:00 Panel 4: Understanding the Risks to Healthcare 
 Workers  
Moderator: Bill Kojola 
 
Objective:  
• Examine influenza transmission risks in 
various healthcare settings. 
 
2:15–3:30 Panel Presentations 
• Overview 
Bill Borwegen, Service Employees 
International Union  
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• Hospital Workers   
Katherine Cox, American Federation 
 of State, County, and Municipal 
Employees 
• Direct Care Workers/Home Setting 
Jane Lipscomb, University of 
Maryland 
• Emergency Response and Emergency 
 Rooms 
Alex Isakov, Emory University  
3:30–4:00 General Discussion 
 
4:00–5:00 Public Comment 
 (preregistered speakers—5 minutes each) 
 
1. Laurel Alvarez, 3M 
2. Rich Duffy, International Association of Fire 
Fighters 
3. Ruth Carrico, Association for Professionals in 
Infection Control and Epidemiology 
4. Bonnie Castillo, California Nurses Association 
5. Enjoli DeGrasse, International Brotherhood of 
Teamsters 
6. Lisa Maragakis, Society for Healthcare 
Epidemiology of America 
7. James Melius, Laborers Health and Safety Fund of 
North America 
8. Jan Rodolfo, California Nurses Association 
9. Peg Seminario, American Federation of Labor and 
Congress of Industrial Organizations 
10. Wava Truscott, Kimberly-Clark Health Care  
11. Stan Weinberg, Wein Products 
12. Gamunu Wijetunge, National Highway Traffic 
Safety Administration 
 
5:00 p.m. ADJOURN 
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Thursday, August 13, 2009 
Lecture Room 




7:30–8:00 a.m. Continental Breakfast 
 
8:00–8:15 Welcome and Goals for the Morning 
 Kenneth Shine, Chair 
 
8:15–10:15 Panel 5: Personal Protective Equipment 
 Moderator: Howard Cohen 
 
Objectives:  
• Examine research on the efficacy and effectiveness 
of medical masks, respirators, and other personal 
protective equipment in preventing the transmission 
of influenza. 
• Discuss issues regarding the effective use of 
personal protective equipment. 
 
8:15–9:30 Panel Presentations 
Roland BerryAnn, National Institute for 
Occupational Safety and Health  
Lisa Brosseau, University of Minnesota  
Lewis Radonovich, Department of 
Veterans Affairs 
Werner Bischoff, Wake Forest University 
 
9:30–10:15 General Discussion  
 
10:15–11:45 Panel 6: Decision Criteria for Infection Control 
Measures 
  Moderator: Sundaresan Jayaraman 
 
 Objectives:  
• Discuss criteria for making decisions on infection 
control measures for nH1N1, specifically regarding 
personal protective equipment.  
• Compare decision criteria for H1N1, seasonal 
influenza, and SARS. 
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10:15–11:15 Panel Presentations 
Bonnie Henry, British Columbia Centre 
 for Disease Control 
Carmem Pessoa de Silva, World Health 
 Organization (via phone) 
Leonard Mermel, Brown University  
Michael Hodgson, Department of 
 Veterans Affairs 
  
11:15–11:45 General Discussion  
 
11:45 a.m.–12:00 p.m. Summary 
 
12:00 p.m. ADJOURN  
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 of Medicine 
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KENNETH I. SHINE, M.D. (Chair), is Executive Vice Chancellor for 
Health Affairs of the University of Texas System, which oversees the six 
University of Texas health institutions, including medical, dental, and 
public health schools. He is the former President of the Institute of Medi-
cine (IOM) at the National Academies, and was the founding Director of 
the RAND Center for Domestic and International Health Security. Dr. 
Shine is Professor of Medicine Emeritus at the University of California, 
Los Angeles (UCLA) School of Medicine, where he served as dean and 
provost prior to his appointment at the IOM. A cardiologist and physi-
ologist, he has an A.B. in biochemical sciences from Harvard College 
and an M.D. from Harvard Medical School. He is a Fellow of the Ameri-
can College of Cardiology and American College of Physicians and is a 
member of many other honorary and academic societies, including the 
Institute of Medicine. He served as Chairman of the Council of Deans of 
the Association of American Medical Colleges from 1991–1992, and was 
President of the American Heart Association from 1985–1986. Dr. 
Shine’s many publications are not only in the field of cardiology but also 
on issues of medical research, public health, and public policy. He has 
served as an advisor to many national commissions and chaired a number 
of IOM studies. 
 
M. E. BONNIE ROGERS, Dr.PH, COHN-S, LNNC, FAAN (Vice 
Chair) is an associate professor of nursing and public health and director 
of the North Carolina Occupational Safety and Health Education and 
Research Center and the Occupational Health Nursing Program at the 
University of North Carolina, School of Public Health, Chapel Hill. Dr. 
Rogers received her diploma in nursing from the Washington Hospital 
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Center School of Nursing, Washington, DC; her baccalaureate in nursing 
from George Mason University, School of Nursing, Fairfax, Virginia; 
and her master of public health degree and doctorate in public health 
from the Johns Hopkins University School of Hygiene and Public 
Health. Dr. Rogers was a visiting scholar at the Hasting Center in New 
York and is an ethics consultant. She is certified in occupational health 
nursing and as a legal nurse consultant. Dr. Rogers is a fellow in the 
American Academy of Nursing and the American Association of Occu-
pational Health Nurses. Dr. Rogers serves as chairperson of the NIOSH 
National Occupational Research Agenda Liaison Committee. She has 
served on numerous Institute of Medicine committees including the 
Committee on Personal Protective Equipment for Healthcare Workers 
During an Influenza Pandemic and on the IOM Standing Committee on 
Personal Protective Equipment for Workplace Safety and Health. Dr. 
Rogers has served in leadership positions for occupational health profes-
sional societies and is past president of the American Association of Oc-
cupational Health Nurses and the Association of Occupational and 
Environmental Clinics. She is currently Vice President of the Interna-
tional Commission on Occupational Health.  
 
GLORIA ADDO-AYENSU, M.D., M.P.H., is the Director of Health 
for Fairfax County. In this capacity she provides overall direction for 
public health programs in the county, including emergency preparedness. 
She has led Fairfax County’s comprehensive pandemic influenza prepar-
edness efforts and engaged a wide range of community stakeholders in 
the process. As past Chair of the Metropolitan Washington Council of 
Governments Health Officials Committee, she facilitated initial coordina-
tion of the National Capital Region’s pandemic planning in 2006. Dr. 
Addo-Ayensu is interested in international health and has served as a 
consultant to research and public health programs in Ghana. 
 
HOWARD J. COHEN, Ph.D., is professor emeritus (formerly professor 
and chair of the Occupational Safety and Health Department) at the Uni-
versity of New Haven. He is an associate (adjunct) professor at Yale 
University’s department of Occupational and Environmental Medicine. 
He formerly was the manager of industrial hygiene at the Olin Corpora-
tion and editor in chief of the American Industrial Hygiene Association 
(AIHA) Journal. He is a graduate of Boston University where he received 
a B.A. degree in biology. Dr. Cohen received his master of public health 
and doctorate of philosophy degrees in industrial health from the Univer-
Copyright © National Academy of Sciences. All rights reserved.
Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A: A Letter Report
http://www.nap.edu/catalog/12748.html
APPENDIX C 55 
 
sity of Michigan. He is certified in the comprehensive practice of indus-
trial hygiene by the American Board of Industrial Hygiene. Dr. Cohen is 
the former chair of the American National Standards Institute Z88.2 
committee on respiratory protection and a current member of the edito-
rial board of the Journal of Occupational and Environmental Hygiene. 
He is the past chair of the AIHA’s respiratory protection committee, a 
past president of the Connecticut River Valley Chapter of the American 
Industrial Hygiene Association, and a past officer and treasurer of the 
American Board of Industrial Hygiene. Dr. Cohen served on the IOM 
Committee on Personal Protective Equipment for Healthcare Workers 
During an Influenza Pandemic and on the IOM Standing Committee on 
Personal Protective Equipment for Workplace Safety and Health. He is 
currently working as a consultant to the Veterans Administration’s North 
Florida/South Georgia Center for Occupational Safety and Infectious 
Disease (on the advisory board and assisting on an upcoming clinical 
study of influenza). Dr. Cohen is also a consultant to a pharmaceutical 
company that has developed the first FDA/NIOSH certified antiviral N95 
surgical respirator. 
 
LEWIS R. GOLDFRANK, M.D. (IOM), is professor and chair of 
emergency medicine, New York University School of Medicine. He is 
the medical director of the New York City Poison Control Center. Dr. 
Goldfrank served as president of the Society of Academic Emergency 
Medicine and chaired the American Board of Emergency Medicine’s 
Subboard on Medical Toxicology. He is coeditor of the Agency for Toxic 
Substances and Disease Registry’s Medical Guidelines for Managing 
Hazmat Incidents, and senior editor of Goldfrank’s Toxicologic Emer-
gencies, a standard text in medical toxicology. Dr. Goldfrank is a mem-
ber of the IOM and chaired both the IOM Committee on Responding to 
the Psychological Consequences of Terrorism and the IOM Standing 
Committee on Personal Protective Equipment for Workplace Safety and 
Health. He recently chaired the IOM Committee on Personal Protective 
Equipment for Healthcare Workers During an Influenza Pandemic. He 
currently chairs the Forum on Medical and Public Health Preparedness 
for Catastrophic Events. 
 
SUNDARESAN JAYARAMAN, Ph.D., is a professor in the School of 
Polymer, Textile and Fiber Engineering and in the College of Manage-
ment at the Georgia Institute of Technology in Atlanta, Georgia. He and 
his research students have made significant contributions in enterprise 
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architecture and modeling methodologies for information systems; engi-
neering design of intelligent textile structures and processes; and design 
and development of knowledge-based systems for textiles and apparel. 
His group’s research has resulted in the realization of the world’s first 
Wearable Motherboard™ or Smart Shirt. He is currently engaged in 
studying the role of management and technology innovation in health 
care. He received his Ph.D. degree from North Carolina State University, 
in 1984, and the M.Tech. and B.Tech. degrees from the University of 
Madras, India, in 1978 and 1976, respectively. He was involved in the 
design and development of TK!Solver, the first equation-solving pro-
gram from Software Arts, Inc., Cambridge, Massachusetts. Dr. Jayara-
man worked as a product manager at Software Arts, Inc., and at Lotus 
Development Corporation, Cambridge, Massachusetts, before joining 
Georgia Tech in the fall of 1985. Professor Jayaraman is a recipient of 
the 1989 Presidential Young Investigator Award from the National Sci-
ence Foundation for his research in the area of computer-aided manufac-
turing and enterprise architecture. He has served on several Institute of 
Medicine and National Research Council committees including the 
Committee on Personal Protective Equipment for Healthcare Workers 
During an Influenza Pandemic, the IOM Standing Committee on Per-
sonal Protective Equipment for Workplace Safety and Health, and the 
Board on Manufacturing and Engineering Design. 
 
WILLIAM H. KOJOLA, M.S., is the Industrial Hygienist for the 
American Federation of Labor and Congress of Industrial Organizations 
(AFL-CIO) Department of Occupational Safety and Health. His experi-
ence in health and safety spans more than 25 years. During that time, Mr. 
Kojola has been the Director of the Occupational Safety and Health Di-
vision of the Laborers Health and Safety Fund of North America, an oc-
cupational safety and health specialist for the International Brotherhood 
of Boilermakers, and director of safety and health for the United Cement, 
Lime, Gypsum and Allied Workers International Union. Prior to this, he 
was a health research scientist at the University of Illinois School of Pub-
lic Health, studying the human health effects of air and water pollutants. 
With the AFL-CIO, Bill Kojola is responsible for developing strategies 
for securing new safety and health protections through federal and state 
regulations, coordinating with affiliates on and leading a unified labor 
response to proposed OSHA regulations, and representing the AFL-CIO 
before government regulatory agencies on federal advisory committees, 
and consensus standard setting efforts. He also provides technical and 
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strategic support to organizing campaigns on safety and health issues. 
Mr. Kojola holds a B.S. degree in biology and an M.S. degree in genetics 
from the University of Minnesota, and studied toxicology and industrial 
hygiene at the University of Illinois School of Public Health. 
 
RAINA MacINTYRE, MBBS (Hons), M App Epid, FRACP, 
FAFPHM, Ph.D., is Head of the School of Public Health and Commu-
nity Medicine at the University of New South Wales, Australia, and Pro-
fessor of Infectious Diseases Epidemiology. She runs a highly strategic 
research program spanning epidemiology, vaccinology, mathematical 
modelling, public health, and clinical trials in infectious diseases. She 
trained in internal medicine, epidemiology and public health. Her re-
search is supported by NHMRC and ARC grants, and she has received 
international recognition by way of a major award, the Sir Henry Well-
come Medal and Prize, from the U.S. military in 2007 for her work on 
bioterrorism. She has also won the Australian Society for Infectious Dis-
eases Award for Advanced Research in Infectious Diseases. She is best 
known for research in the detailed understanding of the transmission dy-
namics and prevention of infectious diseases, particularly respiratory 
pathogens such as influenza, tuberculosis, and other vaccine-preventable 
infections. She has a particular interest in adult vaccination with a focus 
on the elderly, and in the use of face masks and respirators in the preven-
tion of clinical respiratory viral infections. She has over 120 publications 
in peer reviewed journals and serves on the Scientific Influenza Advisory 
Group to the Chief Medical Officer of Australia. She is an Associate Edi-
tor for Epidemiology and Infection. 
 
MARK NICAS, Ph.D., M.P.H., CIH, is Adjunct Professor of Environ-
mental Health Sciences, and Director of the Industrial Hygiene Program, 
in the Division of Environmental Health Sciences, School of Public 
Health, University of California, Berkeley. Dr. Nicas has two primary 
research areas. First, he develops probability models for pathogen infec-
tion via relevant exposure pathways including inhalation, surface-to-
hand-to-face contact, and droplet spray. He has applied a multiple path-
way exposure model to examine the relative contribution of different 
pathways to influenza virus infection risk. Second, he develops mathe-
matical models to estimate exposure intensity to airborne chemical toxi-
cants, both particulate and gas-phase. Such models consider the pollutant 
emission rate and the dispersion pattern in air. Past research involved 
probability modeling of variability in the efficacy of personal respiratory 
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protection, and risk analyses for M. tuberculosis infection and disease 
incidence among healthcare workers. Dr. Nicas received a B.S. in Biol-
ogy/Chemistry from the City College of New York, a M.S. in Genetics 
from the University of Wisconsin, and M.P.H. and Ph.D. degrees from 
the University of California, Berkeley. He is an editorial board member 
of the Journal of Occupational and Environmental Hygiene and the 
Journal of Applied Biosafety, a recipient of the Edward J. Baier Techni-
cal Achievement Award from the American Industrial Hygiene Associa-
tion, and a Fellow of that same association. 
 
PETER PALESE, Ph.D., is a Professor of Microbiology and Chair of 
the Department of Microbiology at the Mount Sinai School of Medicine 
in New York. His scientific publications include research on the replica-
tion of RNA-containing viruses with a special emphasis on influenza 
viruses, which are negative-strand RNA viruses. Specifically, he estab-
lished the first genetic maps for influenza A, B, and C viruses, identified 
the function of several viral genes, and defined the mechanism of neura-
minidase inhibitors (which are now FDA-approved antivirals). Dr. Palese 
also pioneered the field of reverse genetics for negative strand RNA vi-
ruses, which allows the introduction of site-specific mutations into the 
genomes of these viruses. This technique is crucial for the study of the 
structure/function relationships of viral genes, for investigation of viral 
pathogenicity, and for development and manufacture of influenza virus 
vaccines. In addition, an improvement of the technique has been effec-
tively used to reconstruct and study the pathogenicity of the highly viru-
lent but extinct 1918 pandemic influenza virus. His recent work in 
collaboration with Garcia-Sastre has revealed that most negative strand 
RNA viruses possess proteins with interferon antagonist activity, ena-
bling them to counteract the antiviral response of the infected host. Dr. 
Palese was elected to the National Academy of Sciences in 2000 for his 
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